Targeted Therapies For Treatment of Lung Cancer – Recent Advances

Abstract

In both men and women, Lung cancer is the number one cause of cancer-related death. The disorder is especially difficult to detect, and often develops for elderly patients at an advanced stage. Within a year of treatment, more than half of those diagnosed with lung cancer die and 5- year survival is less than 18%. Majority of all lung cancer cases are attributed to Non Small Cell Lung Cancer. Significant advancements in research and diagnosis over the past 10 years have though, culminated in the first improvements made in lung cancer survival. New developments in lung cancer’s cellular pathogenesis and biological activity have culminated in the advancement of rationally developed approaches for early detection, prevention, and treatment of this illness. There are currently several novel treatments in clinical practice, including those that target actionable mutations and more recently immunotherapy. This review will outline developments and emerging debates in lung cancer treatment.